UK Organ Preservation Market Research Report By Solution (University of Wisconsin Solution, Custodial HTK, Collins Solution, Celsior Solution, Perfadex, Citrate Solution), By Preservation Techniques (Static Cold Storage, Dynamic Cold Storage), By Organ Type (Kidney, Liver, Heart, Lungs) and By End User (Hospitals & Clinics, Organ Banks) - Forecast to 2035

UK Organ Preservation Market Overview

As per MRFR analysis, the UK Organ Preservation Market Size was estimated at 12.05 (USD Million) in 2023. The UK Organ Preservation Market Industry is expected to grow from 12.75(USD Million) in 2024 to 30.92 (USD Million) by 2035. The UK Organ Preservation Market CAGR (growth rate) is expected to be around 8.387% during the forecast period (2025 - 2035).

Key UK Organ Preservation Market Trends Highlighted

The UK Organ Preservation Market is witnessing significant trends primarily driven by advancements in preservation technology. The increasing demand for organ transplants is a crucial market driver, propelling the need for more efficient organ preservation solutions. Hospitals and research institutions are recognizing the importance of extending organ viability through innovative preservation techniques, which improves transplant outcomes. The UK government has been actively promoting organ donation initiatives, thereby increasing public awareness and acceptance of organ transplants. This supportive policy environment is helping to drive growth in the organ preservation segment.

Additionally, there are various opportunities to be explored, such as improving preservation solutions to enhance the storage time and functionality of organs. Collaborations between biotech firms and healthcare providers are on the rise, as they aim to develop better preservation methods that ensure organs remain viable for transplant longer. The rise of personalized medicine also opens avenues for tailored preservation techniques that meet specific patient needs.

Recent times have shown a trend toward the integration of digital solutions in organ preservation, including monitoring technologies that track organ conditions during transit. The incorporation of AI and data analytics is transforming how organ preservation practices are approached, making it easier to predict and manage organ health during transportation. As the focus on patient-centric healthcare continues to grow, these innovative advancements are likely to have a lasting impact on the UK organ preservation market and the overall healthcare landscape. The UK's commitment to improving organ donation and transplantation processes will continue to shape emerging trends in this sector.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

UK Organ Preservation Market Drivers

Increasing Demand for Organ Transplants

One of the main factors propelling the UK organ preservation market is the rising number of patients in need of organ transplants. According to NHS Blood and Transplant, there are reportedly more than 6,000 people on the UK's transplant waiting list at the moment. In order to prolong the viability of donated organs and raise transplant success rates, this circumstance is creating an urgent demand for effective organ preservation methods. Advanced organ preservation techniques are in greater demand as a result of organizations like the NHS actively seeking to improve transplantation procedures. Given that the number of organ transplant procedures is expected to rise by at least 3% a year, the UK organ preservation market is expected to develop significantly as a result of this growing demand.

Technological Advancements in Preservation Methods

Innovations in preservation technology significantly contribute to the growth of the UK Organ Preservation Market Industry. The introduction of machine perfusion technology enhances organ viability and function pre-transplant. For instance, research funded by the Medical Research Council in the UK has shown that machine perfusion can improve the outcomes of kidney transplants by up to 20%. This drives interest and investment from institutions such as the Royal College of Surgeons, which supports ongoing Research and Development (R&D) initiatives in this area. The advances in technology lead to higher adoption rates among hospitals, fostering growth in the organ preservation sector.

Supportive Government Policies and Initiatives

The UK government promotes initiatives aimed at increasing organ donation rates, significantly impacting the UK Organ Preservation Market Industry. The introduction of the Organ Donation (Deemed Consent) Act in 2020 has similar legislative changes that led to a rise in organ donation registrations by approximately 33% in the first year alone, as reported by NHS Blood and Transplant. This increase necessitates more advanced organ preservation solutions to ensure that a larger number of organs can be successfully utilized, thus driving market growth. The government’s commitment to improving transplant rates underlines the importance of effective organ preservation methods.

UK Organ Preservation Market Segment Insights

Organ Preservation Market Solution Insights

The UK Organ Preservation Market, particularly within the Solution segment, plays a critical role in ensuring the viability of organs for transplantation, contributing significantly to the healthcare landscape. The various solutions employed in organ preservation are vital as they enhance the durability of harvested organs, allowing for better outcomes post-transplantation. The University of Wisconsin Solution is widely utilized in the preservation of organs, specifically kidneys, due to its balanced formulation that effectively maintains cellular integrity throughout the transportation process.

Custodial HTK is favored for its ability to extend preservation times for hearts and livers, making it a crucial component in high-urgency transplant scenarios where time is critical. Collins Solution is also prominent within the UK market, known for its effectiveness in liver preservation, which has led to improvements in organ transplant success rates. Celsior Solution has emerged for its biocompatibility and effectiveness across various organ types, showcasing innovation in organ conservation practices.

Perfadex solution is recognized for its role in preserving lungs, a complex organ that demands precision in its preservation to ensure compatibility and functionality after transplantation. Finally, Citrate Solution has its niche in liver preservation, offering another option for ensuring organ longevity, reflecting the diverse needs of organ transplant teams. Overall, the Solution segment in the UK Organ Preservation Market showcases a series of specialized formulations that address the critical requirements of different organ preservation needs, each solution contributing to the overarching goals of enhancing transplant success and patient outcomes.

The market is witnessing robust growth driven by advancements in technology, the increasing prevalence of organ transplants, and growing awareness of the importance of organ preservation, all of which highlight the significance of these solutions. This segment mirrors larger trends in the healthcare industry as practitioners seek out innovative methods to improve organ transport efficiency, ultimately aiming to reduce wait times and increase the number of successful transplantation procedures in the UK. Furthermore, with the collaboration among healthcare institutions and continuous Research and Development in the field, the market seems poised for further advancements that will undoubtedly shape the future of organ preservation strategies.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Organ Preservation Market Preservation Techniques Insights

The Preservation Techniques segment within the UK Organ Preservation Market plays a crucial role in ensuring the viability of organs for transplant. This segment primarily encompasses methods such as Static Cold Storage and Dynamic Cold Storage, which are essential for maintaining organ integrity prior to surgical procedures. Static Cold Storage is widely utilized due to its simplicity and efficiency in organ preservation, offering a reliable option during transportation and storage. Conversely, Dynamic Cold Storage has gained prominence as it effectively enhances organ quality through active cooling, contributing significantly to organ health.

As the demand for organ transplants continues to rise in the UK, driven by an aging population and increasing rates of chronic diseases, the need for advanced preservation techniques becomes even more pertinent. Relevant statistics indicate that improved preservation methods can lead to better transplant outcomes, thereby reinforcing the importance of innovation in this field. The advancements in technology and techniques targeted at organ preservation have become vital growth drivers in the UK Organ Preservation Market, highlighting opportunities for further Research and Development in techniques that can maximize organ availability and functionality. This evolving landscape reveals the potential for improved health outcomes for patients relying on organ transplants.

Organ Preservation Market Organ Type Insights

The UK Organ Preservation Market is significantly shaped by various organ types including Kidney, Liver, Heart, and Lungs, each playing a crucial role in the landscape of organ transplantation and preservation. Kidneys stand out as they are among the most commonly transplanted organs, underscoring their importance in addressing renal failure in the UK. The Liver segment also commands attention due to the increasing prevalence of liver diseases, driving demand for effective preservation methods. The Heart segment, though more challenging to preserve due to its sensitivity, is vital given the high incidence of cardiovascular diseases across the UK population.

Lungs, essential for respiratory function, are often at risk due to conditions like chronic obstructive pulmonary disease (COPD) and other pulmonary ailments, further spotlighting the need for advancements in lung preservation techniques. Overall, the diversification within the Organ Type segmentation reflects the complexities of organ transplantation and the ongoing efforts to enhance outcomes for recipients, highlighting both the opportunities and challenges within the UK Organ Preservation Market for future growth and innovation. This robust structure enables the market to respond to varying patient needs while aligning with government health initiatives aimed at improving organ donation and transplantation processes in the UK.

Organ Preservation Market End User Insights

The UK Organ Preservation Market is intricately segmented by End User, which primarily includes Hospitals and Clinics as well as Organ Banks. These entities play a vital role in the organ preservation ecosystem, with Hospitals and Clinics facilitating the surgical procedures necessary for organ transplants and often employing advanced preservation techniques to enhance the viability of donated organs. Organ Banks, on the other hand, are responsible for the collection, storage, and distribution of donated organs, ensuring that they are preserved under optimal conditions for future transplantation.

The increasing demand for organ transplants in the UK, driven by a growing population and rising chronic diseases, underscores the significance of these establishments in maintaining effective organ preservation protocols. Technological advancements in preservation methods, alongside regulatory support from health authorities, further bolster the capabilities of these End Users. As they work together to provide life-saving interventions, Hospitals and Clinics, along with Organ Banks, consistently contribute to improving patient outcomes in transplantation, thus reinforcing their dominating role in the UK's organ preservation landscape.

UK Organ Preservation Market Key Players and Competitive Insights

The UK Organ Preservation Market is an essential segment of the healthcare industry, focusing on the methodologies and technologies that ensure the viability and transportation of organs for transplantation. As the demand for organ transplants continues to rise, driven by increasing awareness about organ donation and the prevalence of chronic diseases, the competitive landscape in this market is becoming increasingly dynamic. Businesses operating within this sphere are innovating continuously to enhance preservation techniques, thereby extending the lifespan and functionality of organs during transport. These advances are crucial not only for improving patient outcomes but also for optimizing the logistics of organ transplantation. The UK market is characterized by a blend of established players and innovative startups, each striving to leverage their strengths in technology, research, and partnerships to capture market share and deliver solutions that meet the evolving needs of transplant centers and healthcare professionals.

Brammer BioScience has established a notable presence in the UK's organ preservation scene, capitalizing on its extensive experience and expertise within the biopharmaceutical industry. The company has garnered recognition for its innovative solutions designed to improve organ viability during transportation. One of the key strengths of Brammer BioScience lies in its robust research and development capabilities. The company invests significantly in developing advanced preservation technologies and offers tailored solutions that cater to the unique needs of various types of organs. This focus on customization enables Brammer BioScience to foster strong relationships with healthcare providers, thereby increasing its footprint in the UK market. Furthermore, the company's commitment to quality and regulatory compliance enhances its reputation, making it a preferred partner for organ preservation needs.

TransMedics is another key player in the UK Organ Preservation Market, known for its cutting-edge technologies that significantly improve organ viability and transplantation outcomes. The company’s flagship products, such as the Organ Care System, stand at the forefront of innovation, allowing for dynamic preservation of organs by simulating physiological conditions. This technology is particularly beneficial for heart and lung transplants, giving TransMedics a considerable edge. The company maintains a robust presence in the UK, supported by strategic partnerships with healthcare institutions that facilitate widespread adoption of its solutions. Furthermore, TransMedics has been active in mergers and acquisitions, augmenting its portfolio and expanding its reach within the market. These strategic moves, combined with a focus on advancing organ preservation technologies, underscore the company's strengths and position in the competitive landscape of the UK organ preservation sector.

Key Companies in the UK Organ Preservation Market Include

• Brammer BioScience


• TransMedics


• Tissuetech


• Celsis In Vitro


• Medtronic


• LifeLine Scientific


• Thermo Fisher Scientific


• Bridge to Life


• Fresenius Kabi


• XVivo Perfusion


• OrganOx


• Nanjing Puheng Medical


• SurgiReal


• Waters Corporation

UK Organ Preservation Market Industry Developments

The UK Organ Preservation Market has recently seen significant developments, particularly in advancements related to organ preservation technologies and methodologies. Companies like Brammer BioScience, TransMedics, and XVivo Perfusion have been actively engaged in enhancing preservation techniques to improve transplant success rates. In terms of mergers and acquisitions, no notable mergers were reported regarding the specified companies in recent months; however, ongoing collaborations and partnerships are prevalent within the sector to foster innovation. Market growth has been instrumental, driven by increased public awareness and technological advancements, leading to a positive shift in organ preservation practices. As of March 2023, Medtronic announced new initiatives to enhance organ viability during transportation, which reflects an adaptive strategy in response to growing demand. Furthermore, the LifeLine Scientific organization has made strides in expanding its distribution capabilities within the UK, aiming to tackle the challenges of organ shortage. This market segment has also witnessed a steady rise in governmental support for transplant research, highlighting the UK’s commitment to improving healthcare outcomes associated with organ transplantation and preservation.

UK Organ Preservation Market Segmentation Insights

Organ Preservation Market Solution Outlook

• University of Wisconsin Solution


• Custodial HTK


• Collins Solution


• Celsior Solution


• Perfadex


• Citrate Solution

Organ Preservation Market Preservation Techniques Outlook

• Static Cold Storage


• Dynamic Cold Storage

Organ Preservation Market Organ Type Outlook

• Kidney


• Liver


• Heart


• Lungs

Organ Preservation Market End User Outlook

• Hospitals & Clinics


• Organ Banks

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	12.05(USD Million)
MARKET SIZE 2024	12.75(USD Million)
MARKET SIZE 2035	30.92(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	8.387% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Brammer BioScience, TransMedics, Tissuetech, Celsis In Vitro, Medtronic, LifeLine Scientific, Thermo Fisher Scientific, Bridge to Life, Fresenius Kabi, XVivo Perfusion, OrganOx, Nanjing Puheng Medical, SurgiReal, Waters Corporation
SEGMENTS COVERED	Solution, Preservation Techniques, Organ Type, End User
KEY MARKET OPPORTUNITIES	Advancements in preservation technologies, Increasing demand for organ transplants, Expanding aging population, Regulatory support for preservation methods, Enhanced transport solutions for organs
KEY MARKET DYNAMICS	increasing transplant demands, technological advancements, regulatory changes, rising awareness, strategic partnerships
COUNTRIES COVERED	UK